Ketek (telithromycin) is in the news again. As usual, not for any good that it has brought. The FDA on February 12, 2007 announced yet another label change and now has removed the approval for use in two of the three areas for which it has been proescribed. That screams a clear message -- is anyone listening?

On 21 January 2006 I wrote about a Public Health Advisory from the FDA about Ketek. I noted at that time my observation that the FDA seemed interested in issuing the warning about the drug only after a respected medical journal had published some adverse findings.

Last Modified: Monday, February 26th, 2007 @ 11:39

This entry was posted on Monday, February 26th, 2007 at 11:39 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.